⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25418259 | 1.00 | ATAD2 (0.60) | — | |
| SCHEMBL28216801 | 0.98 | ATAD2 (0.58) | — | |
| Thymine SCHEMBL29232704 | 0.92 | ATAD2 (0.76) | — | |
| SCHEMBL28211067 | 0.87 | ATAD2 (0.47) | — | |
| Pyrimidine SCHEMBL29014623 | 0.85 | ATAD2 (0.46) | — | |
| SCHEMBL28216798 | 0.85 | ATAD2 (0.46) | — | |
| Thiouracil SCHEMBL4958659 | 0.85 | TP53 (0.66) | — | |
| SCHEMBL29041555 | 0.82 | ATAD2 (0.43) | — | |
| SCHEMBL29041552 | 0.81 | ATAD2 (0.42) | — | |
| Triphosphate SCHEMBL27943631 | 0.81 | ATAD2 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 41597 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106907-A1 | FAST PCR BY TANDEM PRIMER EMBEDDED WITH RIBONUCLEOTIDE | CEPHEID (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-12577554-B2 | Methods for purification of messenger RNA | TRANSLATE BIO, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-12569572-B2 | Messenger RNA therapy for the treatment of Friedreich's ataxia | TRANSLATE BIO, INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-12552858-B2 | Methods and compositions for delivering mRNA coded antibodies | TRANSLATE BIO, INC. (US) | 2026-02-17 | — | — | US | claimed |
| EP-4659246-A1 | ELECTROCHEMICAL SYNTHESIS WITH REDOX STABLE NUCLEOTIDES | Atlas Data Storage, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250368986-A1 | ELECTROCHEMICAL SYNTHESIS WITH REDOX STABLE NUCLEOTIDES | ATLAS DATA STORAGE INC (US) | 2025-12-04 | — | — | US | claimed |
| EP-4638717-A2 | ENGINEERED RNA LIGASE VARIANTS | Codexis, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4630010-A1 | ASYMMETRIC SHORT DUPLEX RNA WITH INTERSPERSED DEOXYRIBONUCLEOTIDES AS A GENE SILENCING TECHNOLOGY AND USE THEREOF | 1Globe Health Institute LLC (US) | 2025-10-15 | — | — | EP | claimed |
| US-5659348-A | APPLYING TO A SUBSTRATE | XEROX CORPORATION (US) | 1997-08-19 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| WO-1996032496-A2 | COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES | MICROPROBE CORPORATION (US) | 1996-10-17 | — | — | WO | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| US-5486603-A | Oligonucleotide having enhanced binding affinity | GILEAD SCIENCES, INC. (US) | 1996-01-23 | — | — | US | claimed |
| WO-1994015622-A1 | NUCLEOSIDE DERIVATIVES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | CAMBRIDGE NEUROSCIENCE (US) | 1994-07-21 | — | — | WO | claimed |
| WO-1991006645-A1 | PROCESS FOR MUTAGENESIS OF DOUBLE-STRAND CIRCULAR DNA | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1991-05-16 | — | — | WO | claimed |
| US-4002479-A | ORGANIC SILVER SALT, SILVER HALIDE, AND A REDUCING AGENT | FUJI PHOTO FILM CO., LTD. (JA) | 1977-01-11 | — | — | US | claimed |